Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy

PHASE2UnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Type2 DiabetesDiabetic Retinopathy
Interventions
DRUG

Tangningtongluo tablets

Four pills each time and three times a day after meals.

DRUG

Calcium dobesilate capsules

1 capsule at a time, tid,po.(morning, midday, and evening), used on an empty stomach.

Trial Locations (13)

225012

Yangzhou Hospital of traditional Chinese Medicine, Yangzhou

226006

Affiliated Hospital of Nantong University, Nantong

400011

Chongqing hospital of traditional Chinese Medicine, Chongqing

410021

The First Hospital of Hunan University of Chinese Medicine, Changsha

550003

The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine, Guiyang

561099

People's Hospital of Anshun City Guizhou Province, Anshun

730050

Gansu Provincial Hospital of traditional Chinese Medicine, Lanzhou

750306

Inner Mongolia Hospital of traditional Chinese Medicine, Hohhot

050013

Hebei Provincial Hospital of traditional Chinese Medicine, Shijiazhuang

Unknown

Ineye Hospital of Chendu University of TCM, Chengdu

Banan Hospital Affiliated to Chongqing Medical University, Chongqing

South Central Hospital of Yunnan Province, Honghe Prefecture

Eye Hospital of WMU, Wenzhou

All Listed Sponsors
lead

Guizhou Bailing Group Pharmaceutical Co Ltd

INDUSTRY